L. Stet

发表

ffi cacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or

R. Emsley, D. Naber, J. Panagides, 2013 .

Human teratocarcinoma cells express functional insulin-like growth factor I receptors.

C. Mummery, E. J. V. van Zoelen, S. D. de Laat, 1989, Experimental cell research.

Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.

M. C. V. D. Heuvel, S. Eloot, M. W. van den Heuvel, 2012, British journal of anaesthesia.

Dialysability of sugammadex and its complex with rocuronium in subjects with severe renal impairment: 9AP3-4

G. Cammu, B. V. Vlem, L. Stet, 2011 .

Long-Term Efficacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder: An Extension Study

R. Emsley, D. Naber, J. Panagides, 2012, Pharmacopsychiatry.

Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder: Results of a 12-Week Core Study and 40-Week Extension

J. Calabrese, A. Szegedi, J. Panagides, 2012, Journal of clinical psychopharmacology.

PW01-28 - Asenapine as Adjunctive Treatment For Bipolar Mania: A Placebo-controlled 12-week Study and 40-week Extension

A. Szegedi, J. Zhao, J. Panagides, 2010, European psychiatry.

Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.

E. De Clercq, A. Matsuda, J. Balzarini, 1997, Advances in experimental medicine and biology.

Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder: Results of a 12-Week Core Study and 40-Week Extension

J. Calabrese, A. Szegedi, J. Panagides, 2012, Journal of clinical psychopharmacology.